Reduction of microglial activity in a model of multiple sclerosis by dipyridamole

BACKGROUND: Despite extensive and persistent activation of microglia in multiple sclerosis (MS), microglia inhibitors have not yet been identified for treatment of the disorder. We sought to identify medications already in clinical use that could inhibit the activation of microglia. On the basis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sloka, Scott, Metz, Luanne M, Hader, Walter, Starreveld, Yves, Yong, V Wee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724584/
https://www.ncbi.nlm.nih.gov/pubmed/23866809
http://dx.doi.org/10.1186/1742-2094-10-89

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724584/
https://www.ncbi.nlm.nih.gov/pubmed/23866809
http://dx.doi.org/10.1186/1742-2094-10-89

Ejemplares similares